Transforming growth factor beta 1, a cytokine with regenerative functions

Area of Science:

• Neuroscience
• Regenerative Medicine
• Cell Biology

Background:

• Peripheral nerve injuries, particularly to large nerve trunks, often result in poor functional recovery due to inadequate axonal regeneration.
• This lack of recovery is linked to the loss of growth-supportive Schwann cells in the distal nerve stump.
• Understanding the pathophysiology of chronic nerve injury is crucial for developing effective treatments.

Approach:

• Utilized a chronic nerve injury and delayed repair animal model mimicking human injuries.
• Investigated the effects of transforming growth factor beta 1 (TGF-β1) and forskolin on chronically denervated Schwann cells and axonal regeneration.
• Assessed the impact of TGF-β1 and forskolin on Schwann cell proliferation, gene expression, and growth-supportive capacity.

Key Points:

• TGF-β1 treatment for 6 months significantly enhanced Schwann cell support for axonal regeneration in chronic nerve injuries.
• Combined TGF-β1 and forskolin treatment nearly doubled regenerated axons, demonstrating an additive effect.
• In vivo application of TGF-β1 and forskolin reactivated denervated Schwann cells, induced proliferation, and upregulated regeneration-associated proteins.

Conclusions:

• TGF-β1 and forskolin treatment effectively reactivates chronically denervated Schwann cells.
• This therapeutic approach creates a growth-supportive environment in chronically injured peripheral nerves.
• The combination therapy holds potential for extending and prolonging regenerative responses to promote axonal regeneration.